Prevalence of cardiovascular disease
By 2035, more than 130 million adults, or 45.1% of the U.S. population, are projected to have some form of CVD.
In 2035 total costs of CVD are expected to reach $1.1 trillion. Direct medical costs are projected to reach $748.7 billion. Indirect costs are estimated to reach $368 billion.
Source: American Heart Association’s Heart Disease and Stroke Statistics – 2019 Update
Heart disease & blood pressure
≈50% American adults are impacted by heart disease.
116.4M U.S. adults have high blood pressure.
Source: American Heart Association’s Heart Disease and Stroke Statistics – 2019 Update
1/3 of adults worldwide have high blood pressure.
Source: www.heart.org
High blood pressure is the most common cause of heart disease-related deaths.
Source: www.heart.org
Status of heart failure patients
Care demand is increasing: 600,000 patients are estimated to be living with advanced heart failure in the U.S.
Patients are living longer: 11% decrease in mortality at 5 years following heart failure diagnosis
Stage 3 or stage 4 heart failure: Following myocardial infarction; comparing 2001-2010 mortality to 1991-2000 mortality
Source: AHA’s Heart Disease and Stroke Statistics—2017 Update from The Advisory Board. Cardiovascular Market Trends – February 2019
Share Email Cardiovascular, Q4 2019
